Phanstiel S. Louise 4
4 · MYRIAD GENETICS INC · Filed Aug 6, 2021
Insider Transaction Report
Form 4
Phanstiel S. Louise
Director
Transactions
- Exercise/Conversion
Common Stock
2021-08-05$21.29/sh+30,000$638,700→ 91,646 total - Sale
Common Stock
2021-08-05$35.04/sh−47,881$1,677,741→ 61,646 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-08-05−30,000→ 0 totalExercise: $21.29Exp: 2021-12-02→ Common Stock (30,000 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2021-08-05−30,000→ 0 totalExercise: $25.39Exp: 2021-12-05→ Common Stock (30,000 underlying) - Exercise/Conversion
Common Stock
2021-08-05$25.39/sh+30,000$761,700→ 109,527 total
Holdings
- 21,000(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.49 to $35.50, inclusive. The Reporting Person undertakes to provide to Myriad Genetics, Inc., any security holder of Myriad Genetics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The shares subject to this option are fully vested and exercisable.